UroGen Pharma (URGN) Assets: 2016-2025
Historic Assets for UroGen Pharma (URGN) over the last 9 years, with Sep 2025 value amounting to $185.0 million.
- UroGen Pharma's Assets fell 38.71% to $185.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $185.0 million, marking a year-over-year decrease of 38.71%. This contributed to the annual value of $285.7 million for FY2024, which is 60.23% up from last year.
- Latest data reveals that UroGen Pharma reported Assets of $185.0 million as of Q3 2025, which was down 11.34% from $208.7 million recorded in Q2 2025.
- In the past 5 years, UroGen Pharma's Assets ranged from a high of $301.9 million in Q3 2024 and a low of $95.4 million during Q2 2023.
- Over the past 3 years, UroGen Pharma's median Assets value was $200.6 million (recorded in 2024), while the average stood at $208.3 million.
- As far as peak fluctuations go, UroGen Pharma's Assets slumped by 41.64% in 2021, and later spiked by 195.56% in 2024.
- Over the past 5 years, UroGen Pharma's Assets (Quarterly) stood at $119.7 million in 2021, then climbed by 13.26% to $135.6 million in 2022, then spiked by 31.48% to $178.3 million in 2023, then surged by 60.23% to $285.7 million in 2024, then plummeted by 38.71% to $185.0 million in 2025.
- Its Assets stands at $185.0 million for Q3 2025, versus $208.7 million for Q2 2025 and $247.6 million for Q1 2025.